A major international trial published in The Lancet Oncology has looked at studies from 13 head and neck cancer centers from nine countries around the world. Using the data of 7,895 patients, a research team has found that ...
Feb 13, 2023
0
52
Afamitresgene autoleucel (afami-cel; formerly ADP-A2M4), an adoptive T cell receptor (TCR) therapy targeting the MAGE-A4 cancer antigen, achieved clinically significant results for patients with multiple solid tumor types ...
Jan 9, 2023
0
35
Talking, smiling, eating together—these are all social activities that are inherent to the human experience. But for some head and neck cancer survivors, they are dreaded tasks. These survivors can go through disfiguring ...
Jan 5, 2023
0
3
Black patients with head and neck cancers have twice the death rates of white patients, and a new study suggests race itself underlies those differences.
Dec 19, 2022
0
0
As a group, human papillomaviruses (HPVs) are the most common sexually transmitted infection in the United States. Some forms of the virus are capable of causing cancer in both men and women.
Dec 5, 2022
0
11
A new study from researchers at the University of Colorado Anschutz Medical Campus has identified a less invasive way to treat a subset of head and neck cancers, which could potentially change the standard of care for patients.
Nov 28, 2022
0
45
A promising new study released by the University of Colorado Cancer Center suggests that recurrence of certain cancers can be significantly decreased by irradiating only a select set of lymph nodes near a tumor rather than ...
Nov 16, 2022
0
78
Patients with head and neck cancer who have more genetic material on chromosome 9 in their cancer cells survive three times longer after receiving immunotherapy than those with less genetic material there, a new study finds. ...
Nov 14, 2022
0
591
Artificial intelligence can augment current methods to predict the risk that head and neck cancer will spread outside the borders of neck lymph nodes, according to researchers with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). ...
Oct 22, 2022
0
3
A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial.
Sep 23, 2022
0
3410
